Potential launches from new challengers could start in 2026 with Boehringer Ingelheim and Zealand’s survodutide. Several ...

The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.

KRAS is the most mutated gene in cancer with mutations occurring in 17%–25% of all cancers, affecting millions of patients worldwide.

Experts have developed a breakthrough small-molecule drug, a 'protein degrader'. This molecule, called ACBI3, could potentially lead to new therapies independent of KRAS mutation type, improving ...

Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug, a "protein ...

Spherix Global Insights compiled data from their RealTime Dynamix™ services in Crohn’s Disease, Rheumatoid Arthritis, and Psoriasis, fielded in late April 2024 (n=104 gastroenterologists, 103 ...

For trade group the Pharmaceutical Research and Manufacturers of America (PhRMA), the fight against pricing provisions in the ...

Andrew M Hoffman, DVM, DVSc, DACVIM, will be continuing his term as the Gilbert S Kahn dean of the University of Pennsylvania ...

APAVP launches at ICTMM 2024 to advance veterinary parasitology in Asia, fostering collaboration and addressing zoonotic ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

This Peninsula biotech company started as a way to find a cancer drug for a co-founder's father. It now layoffs show it’s ...

According to recently unveiled statistics by Future Market Insights, the global animal artificial insemination market is set ...